When titrating inspired oxygen, the target arterial oxyhemoglobin saturation is 94–98% for most acutely ill patients, or 88–92% for patients at risk of carbon dioxide retention. These ranges, established by the British Thoracic Society and echoed by other international bodies, represent the balance between correcting dangerously low oxygen levels and avoiding the real harms of giving too much.
Standard Target: 94–98%
For the majority of patients receiving supplemental oxygen, the goal is to bring arterial oxyhemoglobin saturation into the 94–98% range and keep it there. This applies to most emergency and hospital scenarios: pneumonia, sepsis, trauma, post-surgical recovery, and acute heart failure. The British Thoracic Society guideline frames this simply: prescribe oxygen to a target range, monitor the patient, and adjust flow to stay within that range.
Other organizations set slightly different boundaries that land in the same general zone. The World Health Organization, the Society of Critical Care Medicine, and the Thoracic Society of Australia and New Zealand recommend maintaining saturation at 90% or above. A 2018 BMJ expert panel, after reviewing data across respiratory failure, heart attack, and stroke, recommended 90–94% as a general target for most patients. The differences are small, but the shared principle is consistent: aim for normal or near-normal oxygen levels without pushing beyond what the body needs.
Lower Target: 88–92% for CO₂ Retainers
Patients with COPD, severe obesity-related breathing problems, or other conditions that impair their ability to clear carbon dioxide need a more conservative oxygen target of 88–92%. Giving these patients too much oxygen can suppress their drive to breathe and cause dangerous carbon dioxide buildup, a condition called oxygen-induced hypercapnia. Clinical data show that titrating to 88–92% rather than higher saturations results in less respiratory acidosis and better outcomes during acute flare-ups of COPD.
This lower target range is one of the most universally agreed-upon recommendations in oxygen therapy. Every major guideline body that addresses hypercapnia-prone patients lands on the same 88–92% window. If you’re unsure whether a patient falls into this category, conditions like COPD, neuromuscular disease, severe kyphoscoliosis, and morbid obesity with hypoventilation are the classic risk factors.
Why the Curve Matters for Titration
The relationship between oxygen levels in the blood and how much hemoglobin carries isn’t a straight line. It follows an S-shaped curve. At the top of that curve, where saturation is already in the mid-90s, large changes in oxygen tension produce only tiny changes in saturation. The monitor barely budges. But on the steep middle portion of the curve, around 80–90% saturation, even a small drop in oxygen tension causes saturation to fall rapidly.
This is why the target ranges exist where they do. Keeping saturation above 90% keeps you on the flat, stable portion of the curve, where small fluctuations in a patient’s condition won’t send oxygen levels plummeting. It also explains why a reading of 92% in a COPD patient can be perfectly acceptable, while the same number in a previously healthy patient signals a problem worth investigating.
Risks of Overshooting the Target
Oxygen is a drug, and like any drug, more is not automatically better. Sustained exposure to high concentrations of inspired oxygen (above 60%) for 24 hours or more causes direct lung injury. The mechanism involves an overproduction of reactive oxygen species that damage the delicate cells lining the airways and air sacs. The cells responsible for producing surfactant, the substance that keeps air sacs from collapsing, are particularly vulnerable. The result is lung swelling, fluid accumulation, airway collapse, and progressively stiffer lungs.
Even at more moderate levels, pushing saturation well above the target range offers no benefit and may cause harm. In patients with acute respiratory distress syndrome, a major trial published in the New England Journal of Medicine found that a very conservative oxygen strategy (targeting an arterial oxygen tension of 55–70 mmHg) did not improve survival at 28 days compared to a more liberal approach. In fact, by 90 days, mortality was significantly higher in the conservative group (44.4% vs. 30.4%). Patients whose arterial oxygen tension fell below 67 mmHg had increased mortality. The takeaway: both too little and too much oxygen carry real risks, and the safest approach is to stay within the recommended saturation window rather than drifting toward either extreme.
Heart Attack and Stroke Patients
For patients having a heart attack, supplemental oxygen is only recommended if their saturation drops below 90% or they show signs of respiratory distress. If they are hypoxemic or in heart failure, oxygen should be titrated to a target of 94%. Routine oxygen for heart attack patients with normal saturation levels is not supported by current evidence. The same threshold-based approach generally applies to stroke care: treat low oxygen, don’t supplement normal oxygen.
Pulse Oximetry vs. Arterial Blood Gas
In practice, titration relies on pulse oximetry (SpO₂), the number from the finger clip, as a stand-in for true arterial oxyhemoglobin saturation (SaO₂) measured by blood gas analysis. The two usually track closely, but they can diverge. Low blood flow to the fingers, use of vasopressor medications, sepsis, acid-base disturbances, and temperature swings all reduce pulse oximeter accuracy. Skin vasoconstriction caused by alkalosis, for instance, can cause the pulse oximeter to read lower than the actual arterial saturation.
Carbon monoxide poisoning is another classic pitfall. Pulse oximeters can’t distinguish between hemoglobin carrying oxygen and hemoglobin bound to carbon monoxide, so the reading appears falsely normal. When there’s any doubt about the accuracy of a pulse oximeter reading, or when a patient isn’t responding as expected to changes in oxygen flow, arterial blood gas analysis provides the definitive answer.
Choosing the Right Delivery Device
Different oxygen delivery devices offer different levels of precision for titration. A standard nasal cannula increases the fraction of inspired oxygen by roughly 4% per liter of flow, starting at about 24% at 1 liter per minute and reaching approximately 44% at 6 liters per minute. However, at low flow rates below 5 liters per minute, this estimate is less reliable because the patient’s own breathing pattern significantly affects the actual oxygen concentration they inhale.
A Venturi mask is the most precise option for controlled titration. It uses color-coded valves to deliver a fixed, predictable oxygen concentration regardless of the patient’s breathing rate, ranging from 24% (blue valve) up to 60% (green valve). This makes it particularly useful for COPD patients and others who need the 88–92% target, where accidentally overshooting carries real consequences.
Non-rebreather masks deliver 60–90% oxygen at high flow rates and are reserved for severe hypoxemia where rapid correction is the priority. High-flow nasal cannula systems can deliver anywhere from 21% to 100% oxygen at flow rates up to 60 liters per minute, with the advantage of precise control over both flow and concentration independently.